Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

methenamine-sodium biphosphate

methenamine-sodium biphosphate
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Uro-Phosphate TABLET, ORAL 300 mg-434.78 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

methenamine-sodium biphosphate (Uro-Phosphate)

  • 300 mg-434.78 mg tablet 4 to 6 times Daily
  • TWO 300 mg-434.78 mg tablets (Total: 600 mg-869.56 mg) QID

methenamine mandelate (Mandelamine)

  • 500 mg tablet BID
  • TWO 500 mg tablet (Total: 1,000 mg) QID
Last updated: Dec. 26, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved